Our nonchemotherapy group was very small and had very poor outcomes (Table 4); however, the duration from the diagnosis of metastatic disease to the completion of CDK4/6i therapy correlated with the later initiation of chemotherapy. This evidence concerns the gene CDK4 and metastatic neoplasm.